Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Saved in:
| Title: | Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. |
|---|---|
| Authors: | Frei AL; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland., McGuigan A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sinha RRAK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jabbar F; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gneo L; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tomasevic T; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Iveson T; Southampton University, Southampton, UK., Saunders MP; The Christie NHS Foundation Trust, Manchester, UK., Oien KA; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Pezzella F; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Campo L; Department of Oncology, University of Oxford, Oxford, UK., Browne M; Department of Oncology, University of Oxford, Oxford, UK., Glaire M; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Danielsen HE; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom O; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Cancer Research UK Beatson Institute of Cancer Research, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Kerr R; Department of Oncology, University of Oxford, Oxford, UK., Kerr D; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Domingo E; Department of Oncology, University of Oxford, Oxford, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Church DN; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: david.church@well.ox.ac.uk., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK. |
| Corporate Authors: | TransSCOT consortium |
| Source: | The Lancet. Oncology [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. 198-211. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38301689 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Frei+AL%22">Frei AL</searchLink>; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22McGuigan+A%22">McGuigan A</searchLink>; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Sinha+RRAK%22">Sinha RRAK</searchLink>; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Jabbar+F%22">Jabbar F</searchLink>; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Gneo+L%22">Gneo L</searchLink>; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Tomasevic+T%22">Tomasevic T</searchLink>; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Harkin+A%22">Harkin A</searchLink>; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Iveson+T%22">Iveson T</searchLink>; Southampton University, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Saunders+MP%22">Saunders MP</searchLink>; The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Oien+KA%22">Oien KA</searchLink>; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Maka+N%22">Maka N</searchLink>; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Pezzella+F%22">Pezzella F</searchLink>; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Campo+L%22">Campo L</searchLink>; Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Browne+M%22">Browne M</searchLink>; Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Glaire+M%22">Glaire M</searchLink>; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kildal+W%22">Kildal W</searchLink>; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Danielsen+HE%22">Danielsen HE</searchLink>; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Hay+J%22">Hay J</searchLink>; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Edwards+J%22">Edwards J</searchLink>; School of Cancer Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Sansom+O%22">Sansom O</searchLink>; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Cancer Research UK Beatson Institute of Cancer Research, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Kelly+C%22">Kelly C</searchLink>; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Tomlinson+I%22">Tomlinson I</searchLink>; Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kerr+R%22">Kerr R</searchLink>; Department of Oncology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Kerr+D%22">Kerr D</searchLink>; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Domingo+E%22">Domingo E</searchLink>; Department of Oncology, University of Oxford, Oxford, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Church+DN%22">Church DN</searchLink>; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: david.church@well.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Koelzer+VH%22">Koelzer VH</searchLink>; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22TransSCOT+consortium%22">TransSCOT consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. 198-211. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38301689 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(23)00560-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 198 Titles: – TitleFull: Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Frei AL – PersonEntity: Name: NameFull: McGuigan A – PersonEntity: Name: NameFull: Sinha RRAK – PersonEntity: Name: NameFull: Jabbar F – PersonEntity: Name: NameFull: Gneo L – PersonEntity: Name: NameFull: Tomasevic T – PersonEntity: Name: NameFull: Harkin A – PersonEntity: Name: NameFull: Iveson T – PersonEntity: Name: NameFull: Saunders MP – PersonEntity: Name: NameFull: Oien KA – PersonEntity: Name: NameFull: Maka N – PersonEntity: Name: NameFull: Pezzella F – PersonEntity: Name: NameFull: Campo L – PersonEntity: Name: NameFull: Browne M – PersonEntity: Name: NameFull: Glaire M – PersonEntity: Name: NameFull: Kildal W – PersonEntity: Name: NameFull: Danielsen HE – PersonEntity: Name: NameFull: Hay J – PersonEntity: Name: NameFull: Edwards J – PersonEntity: Name: NameFull: Sansom O – PersonEntity: Name: NameFull: Kelly C – PersonEntity: Name: NameFull: Tomlinson I – PersonEntity: Name: NameFull: Kerr R – PersonEntity: Name: NameFull: Kerr D – PersonEntity: Name: NameFull: Domingo E – PersonEntity: Name: NameFull: Church DN – PersonEntity: Name: NameFull: Koelzer VH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2024 Feb Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1474-5488 Numbering: – Type: volume Value: 25 – Type: issue Value: 2 Titles: – TitleFull: The Lancet. Oncology Type: main |
| ResultId | 1 |
